# Extendicare

## PROCEDURE

**MANUAL:** Infection Prevention and Control
**INDEX:** IPC6-P10.06
**SECTION:** Multi-Drug Resistant Organisms (MDROs)
**DESCRIPTION:** Candida auris
**EFFECTIVE DATE:** February 18, 2025
**REVIEWED DATE:** February 11, 2025
**APPROVED BY:** Chief Medical Officer
**MODIFIED DATE:** May 30, 2025

----

## POLICY

### Multi-Drug Resistant Organisms (MDROs)

## PROCEDURE

### Surveillance and Reporting

- Ensure that, prior to admission, the completed application has been reviewed for any history of C. auris and forwarded to the Infection Control Professional/Designate if there is history of infection, colonization or exposure.
- Assess all residents who meet the following Candida auris (C. auris) risk criteria:
- Have had recent surgeries;
- Are diabetic;
- Use broad-spectrum antibiotics and antifungals;
- Have invasive medical devices such as breathing tubes, feeding tubes, and central venous catheters; and/or
- Have frequent stays in health care settings (i.e., particularly in long-term acute care hospitals, and long-term care homes that provide ventilator care).

### Precautions

- If it is determined that a resident may have a C. auris-related infection:
- Notify the Infection Control Professional/Designate.
- Implement Contact Precautions.
- Reinforce with care staff the need for adherence to hand hygiene and the use of personal protective equipment (PPE).
- Conduct appropriate lab testing per Physician/Nurse Practitioner direction.
- Review the resident’s medication records and contact Physician/Nurse Practitioner for further direction if the resident has recently been started on antibiotics.
- Ensure twice-daily cleaning/disinfecting for resident rooms with suspected/confirmed C. auris with an appropriate chemical.

----

**Helping People**
This document is uncontrolled when printed.
Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025

----

**Page 1 of 2**

# PROCEDURE

## SECTION: Multi-Drug Resistant Organisms (MDROs)

### DESCRIPTION: Candida auris

### INDEX: IPC6-P10.06

----

## EDUCATION
1. IPC6-P10-E1 - MDRO Guide
2. IPC6-P10-E6 - Candida auris (C. auris) Fact Sheet

## TOOLS
1. IPC6-P10-T1 – MDRO Screening Tool

----

> Helping people live better

> This document is uncontrolled when printed.

> Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025

----

**Page 2 of 2**